Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Gu Han Medicine: One of the controlling shareholders' concerted action plans to increase their holdings in the company by no less than 20 million yuan
Everyday AI Express, Guhan Pharmaceutical (SZ 000590, closing price: 11.93 yuan) announced on the evening of March 9 that one of the controlling shareholders of Guhan Pharmaceutical Group Co., Ltd., an acting person of Shanghai Sailaxian Enterprise Management Consulting Co., Ltd., based on recognition of the company’s long-term investment value and confidence in future sustainable development, plans to increase its holdings within 6 months from the date of this announcement. The planned increase is not less than 20 million RMB. Before this increase, Shanghai Sailaxian held 1.1 million shares, accounting for 0.46% of the total share capital; Hunan Sailaxian held approximately 58.61 million shares, accounting for 24.47% of the total share capital.
Everyday Headlines (nbdtoutiao)—Exclusive interview with Hu Zejun, Standing Committee Member of the National Committee of the Chinese People’s Political Consultative Conference and Deputy Director of the Population, Resources, and Environment Committee: Increasing high school places and expanding quality undergraduate enrollment aligns with China’s demographic changes.
(Reporter Zeng Jianhui)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Operate at your own risk.
Daily Economic News